Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease

NCT00841789 is registered in ClinicalTrials.gov with Michael Portman as lead sponsor.

NCT NCT00841789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00841789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease
Lead sponsor
Michael Portman
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
August 30, 2018
Enrollment
205 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

kawasaki disease, mucocutaneous lymph node syndrome